Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Harleysville, PA
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Harleysville, PA
Click here to add this to my saved trials
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated:  4/12/2016
mi
from
Latrobe, PA
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated: 4/12/2016
mi
from
Latrobe, PA
Click here to add this to my saved trials
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Sellersville, PA
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Sellersville, PA
Click here to add this to my saved trials
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Wexford, PA
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Wexford, PA
Click here to add this to my saved trials
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Kingsport, TN
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Kingsport, TN
Click here to add this to my saved trials
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated:  4/12/2016
Clinical Research Facility
mi
from
Spokane, WA
Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine
Evaluation of the Persistence of Bactericidal Antibodies in Adolescents and Adults Who Received a Single Dose of Menactra® Four to Eight Years Earlier
Status: Enrolling
Updated: 4/12/2016
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Elite Clinical Studies
mi
from
Phoenix, AZ
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Elite Clinical Studies
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Sherif Khamis MD Inc
mi
from
Canoga Park, CA
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Sherif Khamis MD Inc
mi
from
Canoga Park, CA
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Mills Clinical Research
mi
from
Los Angeles, CA
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Mills Clinical Research
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Planned Parenthood of the Rocky Mountains
mi
from
Denver, CO
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Planned Parenthood of the Rocky Mountains
mi
from
Denver, CO
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Yale School of Medicine
mi
from
New Haven, CT
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Yale School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Perimeter Institute for Clinical Research, Inc. (PICR Clinic)
mi
from
Atlanta, GA
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Perimeter Institute for Clinical Research, Inc. (PICR Clinic)
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Advanced Clinical Research
mi
from
Boise, ID
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Advanced Clinical Research
mi
from
Boise, ID
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Indiana University School of Medicine
mi
from
Indianapolis, IN
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
LSU Health Science Center
mi
from
New Orleans, LA
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
LSU Health Science Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
LSU Health Science Center Shreveport
mi
from
Shreveport, LA
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
LSU Health Science Center Shreveport
mi
from
Shreveport, LA
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
IRC Clinics, Inc.
mi
from
Towson, MD
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
IRC Clinics, Inc.
mi
from
Towson, MD
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
University of Mississippi Medical Center/Crossroads Clinic (MSDH)
mi
from
Jackson, MS
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
University of Mississippi Medical Center/Crossroads Clinic (MSDH)
mi
from
Jackson, MS
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Quality Clinical Research, Inc.
mi
from
Omaha, NE
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Quality Clinical Research, Inc.
mi
from
Omaha, NE
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Rochester Clinical Research Inc.
mi
from
Rochester, NY
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Laboratory Corporation of America
mi
from
Burlington, NC
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Laboratory Corporation of America
mi
from
Burlington, NC
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Westover Heights Clinic
mi
from
Portland, OR
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Westover Heights Clinic
mi
from
Portland, OR
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Planned Parenthood of Southeastern Pennsylvania
mi
from
Philadephia, PA
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Planned Parenthood of Southeastern Pennsylvania
mi
from
Philadephia, PA
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Geneuity Clinical Research Services
mi
from
Maryville, TN
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Geneuity Clinical Research Services
mi
from
Maryville, TN
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Planned Parenthood Gulf Coast
mi
from
Houston, TX
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Planned Parenthood Gulf Coast
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
Center for Clinical Studies
mi
from
Webster, TX
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
Center for Clinical Studies
mi
from
Webster, TX
Click here to add this to my saved trials
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated:  4/14/2016
American Regional University Pathologists
mi
from
Salt Lake City, UT
Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects
Clinical Evaluation of the Aptima® Herpes Simplex Viruses 1 & 2 Assay on the Panther® System in Swab Specimens From Symptomatic Subjects Presenting With a Suspected Herpes Lesion(s)
Status: Enrolling
Updated: 4/14/2016
American Regional University Pathologists
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Aurora, CO
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
New Orleans, LA
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Detroit, MI
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Charlotte, NC
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Philadelphia, PA
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated:  4/14/2016
Clinical Research Facility
mi
from
Dallas, TX
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated: 4/14/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated:  4/14/2016
Site Reference ID/Investigator# 63582
mi
from
Calgary,
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis (TURQUOISE-CPB)
Status: Enrolling
Updated: 4/14/2016
Site Reference ID/Investigator# 63582
mi
from
Calgary,
Click here to add this to my saved trials
Epidemiology of H. Pylori Transmission
Epidemiology of H. Pylori Transmission and Immunoepidemiology of Concomitant Infections
Status: Enrolling
Updated:  4/14/2016
Santa Clara Public Health Clinics
mi
from
San Jose, CA
Epidemiology of H. Pylori Transmission
Epidemiology of H. Pylori Transmission and Immunoepidemiology of Concomitant Infections
Status: Enrolling
Updated: 4/14/2016
Santa Clara Public Health Clinics
mi
from
San Jose, CA
Click here to add this to my saved trials
Epidemiology of H. Pylori Transmission
Epidemiology of H. Pylori Transmission and Immunoepidemiology of Concomitant Infections
Status: Enrolling
Updated:  4/14/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Epidemiology of H. Pylori Transmission
Epidemiology of H. Pylori Transmission and Immunoepidemiology of Concomitant Infections
Status: Enrolling
Updated: 4/14/2016
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Hub Cleansing to Prevent Hub Infection
Hub Cleansing to Prevent Hub Infection
Status: Enrolling
Updated:  4/14/2016
Rush University Medical Center
mi
from
Chicago, IL
Hub Cleansing to Prevent Hub Infection
Hub Cleansing to Prevent Hub Infection
Status: Enrolling
Updated: 4/14/2016
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)
Phase II Pilot Study to Estimate the Adverse Events Associated With the Lock Solution When Used to Salvage Central Venous Catheter (CVC) in the Setting of a Central Line Associated Bloodstream Infection (CLABSI)
Status: Enrolling
Updated:  4/15/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Antimicrobial Catheter Lock Solution for the Treatment of Central Line Associated Bloodstream Infection (CLABSI)
Phase II Pilot Study to Estimate the Adverse Events Associated With the Lock Solution When Used to Salvage Central Venous Catheter (CVC) in the Setting of a Central Line Associated Bloodstream Infection (CLABSI)
Status: Enrolling
Updated: 4/15/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine
Post-licensure Safety Surveillance Study of Routine Use of Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra ™)
Status: Enrolling
Updated:  4/15/2016
Clinical Research Facility
mi
from
Oakland, CA
Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine
Post-licensure Safety Surveillance Study of Routine Use of Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra ™)
Status: Enrolling
Updated: 4/15/2016
Clinical Research Facility
mi
from
Oakland, CA
Click here to add this to my saved trials
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated:  4/27/2016
Advanced Specialty Research
mi
from
Nampa, ID
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated: 4/27/2016
Advanced Specialty Research
mi
from
Nampa, ID
Click here to add this to my saved trials
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated:  4/27/2016
Hutchinson Clinic
mi
from
Hutchinson, KA
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated: 4/27/2016
Hutchinson Clinic
mi
from
Hutchinson, KA
Click here to add this to my saved trials
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated:  4/27/2016
University of Kansas Medical Center Research Institute, Inc.
mi
from
Kansas City, KA
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated: 4/27/2016
University of Kansas Medical Center Research Institute, Inc.
mi
from
Kansas City, KA
Click here to add this to my saved trials
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated:  4/27/2016
Meridian Clinical Research
mi
from
Norfolk, NE
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated: 4/27/2016
Meridian Clinical Research
mi
from
Norfolk, NE
Click here to add this to my saved trials
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated:  4/27/2016
Duke University
mi
from
Durham, NC
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated: 4/27/2016
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated:  4/27/2016
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated: 4/27/2016
Magee-Womens Hospital of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated:  4/27/2016
Baylor College of Medicine
mi
from
Houston, TX
RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.
A Phase II Randomized, Observer-Blind, Placebo-Controlled, Study to Evaluate the Safety and Immunogenicity of a Respiratory Syncytial Virus (RSV) F Nanoparticle Vaccine With Aluminum, in Healthy Third-trimester Pregnant Women and to Assess the Impact of Maternal Immunization on Infant Safety Through One Year of Life
Status: Enrolling
Updated: 4/27/2016
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection
Phase 2a, Randomized, Double-Blind Study to Investigate the Safety and Efficacy of Faldaprevir in Combination With Ribavirin and TD-6450 for 12 Weeks in Treatment-Naive Patients Chronically Infected With Genotype 4 Hepatitis C Virus
Status: Enrolling
Updated:  4/27/2016
Southern California Research Center
mi
from
Coronado, CA
A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection
Phase 2a, Randomized, Double-Blind Study to Investigate the Safety and Efficacy of Faldaprevir in Combination With Ribavirin and TD-6450 for 12 Weeks in Treatment-Naive Patients Chronically Infected With Genotype 4 Hepatitis C Virus
Status: Enrolling
Updated: 4/27/2016
Southern California Research Center
mi
from
Coronado, CA
Click here to add this to my saved trials
Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients
A Phase 1, Open-Label, Multi-Center, Two-Part, Single-Dose, Parallel Design, Safety, Tolerance, and Pharmacokinetic Study of Orally and Intravenously Administered TR-701 FA in 12 to 17 Year Old Adolescent Patients
Status: Enrolling
Updated:  5/2/2016
Trius Investigator Site 003
mi
from
Little Rock, AR
Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients
A Phase 1, Open-Label, Multi-Center, Two-Part, Single-Dose, Parallel Design, Safety, Tolerance, and Pharmacokinetic Study of Orally and Intravenously Administered TR-701 FA in 12 to 17 Year Old Adolescent Patients
Status: Enrolling
Updated: 5/2/2016
Trius Investigator Site 003
mi
from
Little Rock, AR
Click here to add this to my saved trials